da Vinci (and Ion)

Intuitive Surgical (NASDAQ: ISRG; founded 1995, Sunnyvale, California) is the dominant incumbent and verified gold standard of surgical robotics. Its da Vinci platform spans the multi-port X and Xi systems, the SP single-port system, and the fifth-generation da Vinci 5, which the FDA cleared via 510(k) on March 14, 2024 with a headline Force Feedback sensing feature, alongside the Ion endoluminal robotic bronchoscopy system cleared in February 2019. As of its SEC Form 10-Q for the quarter ended March 31, 2026, the verified installed base was 11,395 da Vinci systems, up 12 percent year over year and including 1,464 da Vinci 5 units, plus 1,041 Ion systems, up 22 percent, with worldwide procedures growing about 17 percent. Surgical robotics sits in the registry as a deliberate axis-extension: physical AI operating in the medical regulatory regime, where FDA clearance is the verified gating event for maturity, and Intuitive clears it across multiple platforms and generations, placing it at production maturity. On AI substance, da Vinci is a master-slave teleoperated system with shipped analytics-grade AI such as Case Insights and machine-vision interface features, and Force Feedback is a shipped sensing feature rather than autonomy; autonomous suturing and tissue manipulation via vision-language models are research demonstrations on da Vinci hardware, not shipped features, and the 4,000-mile telesurgery demonstration is investigational. The widely cited 43-percent-less-force figure is preclinical and marketing-sourced rather than an outcomes-verified clinical result.

da Vinci (and Ion) is listed at $1,800,000 to $2,500,000 on the DEPLOY registry. This is an analyst estimate, not an official price.

Yes. da Vinci (and Ion) is independently verified in real-world operation on the DEPLOY registry, confirmed at named deployment sites with primary sources: not a concept, render, or demo-only.

Not verified as fully autonomous. da Vinci (and Ion)'s capabilities on the DEPLOY registry are recorded as teleoperated-assisted, demonstrated-only, or vendor claims (Assists surgery), not independently confirmed to run without a human in the loop.

da Vinci (and Ion)'s recorded specifications on the DEPLOY registry: Degrees of freedom: 7; Height: 175.3 cm; Weight: 544 kg. See the Specs section for the full sourced set.

da Vinci (and Ion) is made by Intuitive Surgical, based in Sunnyvale, California, USA, founded in 1995.

15 verified deployments of da Vinci (and Ion) are on the DEPLOY registry, including at United States (multiple hotel chains), Global (multiple sites), Tampa, Florida, USA.

da Vinci (and Ion) is in commercial deployment and is sold to operators; contact the manufacturer to buy, and see the pricing section for any recorded price.

da Vinci (and Ion) has 10 regulatory records on the DEPLOY registry: FDA recall (Z-1232-2026), recalled; FDA recall (Z-1262-2023), recalled; FDA recall (Z-0340-2023), recalled and 7 more. See the Regulatory filings section for each agency source.

On the DEPLOY registry, comparable surgical robots to da Vinci (and Ion) include Edge Multi-Port Surgical Robot, Edison Histotripsy System, Stryker Mako SmartRobotics, Toumai.

da Vinci (and Ion) and Edge Multi-Port Surgical Robot (Edge Medical Robotics · 14 deployments) are both surgical robots on the DEPLOY registry. da Vinci (and Ion) has 15 verified deployments on record. Compare both records for specs, safety, deployments, and verified-vs-claimed autonomy.

On DEPLOY's intelligence score, which blends verified deployments, safety, adoption, media, and IP signals, da Vinci (and Ion) ranks in roughly the top under 1% of surgical models tracked by the registry.

da Vinci (and Ion) is at the production stage on the DEPLOY maturity ladder (research, prototype, pilot, commercial, production). Production stage means high-volume manufacture and commercial-scale deployments are sustained.

da Vinci (and Ion) has 56 active incidents on record in the DEPLOY registry. 47 recalls and 9 incidents on record (2 catastrophic, 4 critical, 39 serious, 9 moderate, 2 minor). Most recent: Jun 2026. Retracted incidents are excluded from this count.

The da Vinci Xi costs approximately $1.5 to $2.5 million. The latest da Vinci 5 ranges from $1.8 to $2.5 million. The entry-level da Vinci X costs $0.8 to $1.8 million. Annual maintenance fees total about 10% of the initial purchase price. The average selling price of a da Vinci Xi is approximately $1.42 million.